Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS)
CNY 49.04
(-1.9%)
CNY 49.04
(-1.9%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.02 Billion CNY | 57.59% |
| 2022 | 651.29 Million CNY | 1.15% |
| 2021 | 643.86 Million CNY | 13.58% |
| 2020 | 566.87 Million CNY | 52.58% |
| 2019 | 371.53 Million CNY | 45.4% |
| 2018 | 255.52 Million CNY | 11.65% |
| 2017 | 228.86 Million CNY | 2752.79% |
| 2016 | 8.02 Million CNY | -8.6% |
| 2015 | 8.77 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 355.1 Million CNY | 10.4% |
| 2024 Q3 | 420.75 Million CNY | -10.92% |
| 2024 Q2 | 472.32 Million CNY | 33.01% |
| 2023 Q4 | 321.65 Million CNY | 4.2% |
| 2023 FY | 1.02 Billion CNY | 57.59% |
| 2023 Q1 | 208.05 Million CNY | -22.67% |
| 2023 Q2 | 192.72 Million CNY | -7.37% |
| 2023 Q3 | 308.68 Million CNY | 60.17% |
| 2022 Q4 | 269.05 Million CNY | 136.14% |
| 2022 FY | 651.29 Million CNY | 1.15% |
| 2022 Q2 | 134.05 Million CNY | -0.14% |
| 2022 Q1 | 134.24 Million CNY | -30.8% |
| 2022 Q3 | 113.93 Million CNY | -15.01% |
| 2021 FY | 643.86 Million CNY | 13.58% |
| 2021 Q4 | 193.99 Million CNY | 37.71% |
| 2021 Q2 | 142.81 Million CNY | -14.07% |
| 2021 Q3 | 140.87 Million CNY | -1.36% |
| 2021 Q1 | 166.19 Million CNY | -13.51% |
| 2020 Q1 | 46.34 Million CNY | -56.34% |
| 2020 Q4 | 192.14 Million CNY | 21.27% |
| 2020 FY | 566.87 Million CNY | 52.58% |
| 2020 Q2 | 169.94 Million CNY | 266.71% |
| 2020 Q3 | 158.44 Million CNY | -6.77% |
| 2019 Q3 | 102.34 Million CNY | 3.94% |
| 2019 FY | 371.53 Million CNY | 45.4% |
| 2019 Q4 | 106.14 Million CNY | 3.71% |
| 2019 Q2 | 98.46 Million CNY | 52.46% |
| 2019 Q1 | 64.58 Million CNY | 35.1% |
| 2018 Q4 | 47.8 Million CNY | -12.91% |
| 2018 FY | 255.52 Million CNY | 11.65% |
| 2018 Q1 | 33.12 Million CNY | -56.8% |
| 2018 Q2 | 119.71 Million CNY | 261.43% |
| 2018 Q3 | 54.88 Million CNY | -54.15% |
| 2017 Q3 | 56.8 Million CNY | -27.74% |
| 2017 FY | 228.86 Million CNY | 2752.79% |
| 2017 Q1 | 16.78 Million CNY | 291.69% |
| 2017 Q4 | 76.67 Million CNY | 34.98% |
| 2017 Q2 | 78.6 Million CNY | 368.19% |
| 2016 Q2 | 667.69 Thousand CNY | -0.0% |
| 2016 Q4 | 4.28 Million CNY | 0.0% |
| 2016 Q3 | 4.28 Million CNY | 541.96% |
| 2016 Q1 | 667.69 Thousand CNY | -16.61% |
| 2016 FY | 8.02 Million CNY | -8.6% |
| 2015 Q1 | 3.58 Million CNY | 0.0% |
| 2015 Q2 | 3.58 Million CNY | 0.0% |
| 2015 Q4 | 800.66 Thousand CNY | 0.0% |
| 2015 FY | 8.77 Million CNY | 0.0% |
| 2015 Q3 | 800.66 Thousand CNY | -77.68% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |